Literature DB >> 9013368

Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache.

B P Schachtel1, S A Furey, W R Thoden.   

Abstract

A single-dose, double-blind, randomized clinical trial was conducted to examine the relative analgesic effectiveness of 400 mg of ibuprofen (n = 153), 1,000 mg of acetaminophen (n = 151), and placebo (n = 151) in volunteers with muscle contraction headache. At regular intervals during a 4-hour period, participants evaluated headache pain intensity on a 100-mm visual analog scale and headache pain relief on a six-category scale. Both active agents were significantly different from placebo at all time points and in reducing pain intensity and providing relief of headache overall. Similarly, ibuprofen at 400 mg differed significantly from acetaminophen at 1,000 mg on both rating scales. Participants receiving ibuprofen at 400 mg achieved complete relief of headache faster than those receiving acetaminophen at 1,000 mg or placebo, and more participants taking ibuprofen experienced complete relief of headache than those taking placebo or acetaminophen. Both ibuprofen at 400 mg and acetaminophen at 1,000 mg are efficacious analgesic agents for muscle contraction headache, and ibuprofen at 400 mg is significantly more effective than acetaminophen at 1,000 mg for treating this condition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013368     DOI: 10.1002/j.1552-4604.1996.tb04165.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  14 in total

1.  The use of ibuprofen plus caffeine to treat tension-type headache.

Authors:  S Diamond; F G Freitag
Journal:  Curr Pain Headache Rep       Date:  2001-10

2.  Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.

Authors:  Adrienne E Faerber; David H Kreling
Journal:  J Gen Intern Med       Date:  2014-01       Impact factor: 5.128

Review 3.  Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review.

Authors:  Boris Filipović; J Alexander de Ru; Rick van de Langenberg; Pepijn A Borggreven; Zdravko Lacković; Peter J F M Lohuis
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-01-25       Impact factor: 2.503

Review 4.  Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults.

Authors:  Guy Stephens; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-06-16

Review 5.  Headache in primary care: how important is diagnosis to management?

Authors:  Norma O'Flynn; Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

Review 6.  Current and potential future drug therapies for tension-type headache.

Authors:  Sait Ashina; Messoud Ashina
Journal:  Curr Pain Headache Rep       Date:  2003-12

Review 7.  Ibuprofen for acute treatment of episodic tension-type headache in adults.

Authors:  Sheena Derry; Philip J Wiffen; R Andrew Moore; Lars Bendtsen
Journal:  Cochrane Database Syst Rev       Date:  2015-07-31

8.  The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip.

Authors:  F Boureau; H Schneid; N Zeghari; R Wall; P Bourgeois
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

9.  A Comparison of Efficacy and Safety of Non-steroidal Anti-inflammatory Drugs versus Acetaminophen in the Treatment of Episodic Tension-type Headache: A Meta-analysis of Randomized Placebo-controlled Trial Studies.

Authors:  Yeo Jung Yoon; Ju Heon Kim; Soo Young Kim; In Hong Hwang; Mi Ra Kim
Journal:  Korean J Fam Med       Date:  2012-09-27

10.  Onset of analgesia and efficacy of ibuprofen sodium in postsurgical dental pain: a randomized, placebo-controlled study versus standard ibuprofen.

Authors:  Patrick Brain; Rina Leyva; Geraldine Doyle; David Kellstein
Journal:  Clin J Pain       Date:  2015-05       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.